AURA
Aura Biosciences Inc
6.50$
+1.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +63.3% | +0.5% | +41.0% | +10.0% | -5.6% | – | |
| – | – | – | – | – | – | – | |
| – | -5.6% | +39.5% | +67.9% | +51.4% | +14.6% | +23.2% | |
| – | -7.9% | +142.3% | +79.0% | +9.4% | +15.5% | -1.4% | |
| – | -6.0% | +58.7% | +71.0% | +38.8% | +14.8% | +17.3% | |
| – | – | – | – | – | – | – | |
| – | -40.0% | +333.3% | +6,438.5% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | -40.0% | -27,766.7% | – | – | -18.2% | -3.6% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.